A high excision potential of TALENs for integrated DNA of HIV-based lentiviral vector

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Ebina, Hirotaka ^a   Kanemura, Yuka ^a   Misawa, Naoko ^a   Sakuma, Tetsushi ^b   Kobayashi, Tomoko ^c   Yamamoto, Takashi ^b   Koyanagi, Yoshio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; CRISPR ASSOCIATED PROTEIN; LENTIVIRUS VECTOR; MESSENGER RNA; TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE; VIRUS DNA;

ARTICLE; CD4+ T LYMPHOCYTE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CONTROLLED STUDY; DNA CLEAVAGE; DNA INTEGRATION; FLOW CYTOMETRY; GENE DISRUPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; LONG TERMINAL REPEAT; MEMORY CELL; NONHUMAN; PLASMID; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS REACTIVATION; WESTERN BLOTTING; CELL LINE; CRISPR CAS SYSTEM; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; VIRUS DNA CELL DNA INTERACTION;

HUMAN IMMUNODEFICIENCY VIRUS;

CELL LINE; CRISPR-CAS SYSTEMS; DNA, VIRAL; GENETIC VECTORS; HIV-1; HUMANS; TRANSDUCTION, GENETIC; VIRUS INTEGRATION;

EID: 84924943941     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120047     Document Type: Article

References (46)

1. Urnov FD, Miller JC, Lee YL, Beausejour CM, Rock JM, Augustus S, et al. (2005) Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435: 646-651. PMID: 15806097
2. Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD (2010) Genome editing with engineered zinc finger nucleases. Nat Rev Genet 11: 636-646. doi: 10.1038/nrg2842 PMID: 20717154
3. Mahfouz MM, Li L, Shamimuzzaman M, Wibowo A, Fang X, Zhu JK (2011) De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks. Proc Natl Acad Sci U S A 108: 2623-2628. doi: 10.1073/pnas.1019533108 PMID: 21262818
4. Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S, et al. (2009) Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326: 1509-1512. doi: 10.1126/science.1178811 PMID: 19933107
5. Moscou MJ, Bogdanove AJ (2009) A simple cipher governs DNA recognition by TAL effectors. Science 326: 1501. doi: 10.1126/science.1178817 PMID: 19933106
6. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, et al. (2013) RNA-guided human genome engineering via Cas9. Science 339: 823-826. doi: 10.1126/science.1232033 PMID: 23287722
7. Sander JD, Joung JK (2014) CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol 32: 347-355. doi: 10.1038/nbt.2842 PMID: 24584096
8. Huang P, Xiao A, Zhou M, Zhu Z, Lin S, Zhang B (2011) Heritable gene targeting in zebrafish using customized TALENs. Nat Biotechnol 29: 699-700. doi: 10.1038/nbt.1939 PMID: 21822242
9. Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, et al. (2013) One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering. Cell 153: 910-918. doi: 10.1016/j.cell.2013.04.025 PMID: 23643243
10. Hutter G, Nowak D, Mossner M, Ganepola S, Mussig A, Allers K, et al. (2009) Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 360: 692-698. doi: 10.1056/NEJMoa0802905 PMID: 19213682
11. rd (2013) ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 31: 397-405. doi: 10.1016/j.tibtech.2013.04.004 PMID: 23664777
12. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F (2013) Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8: 2281-2308. doi: 10.1038/nprot.2013.143 PMID: 24157548
13. Perez EE, Wang J, Miller JC, Jouvenot Y, Kim KA, Liu O, et al. (2008) Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 26: 808-816. doi: 10.1038/nbt1410 PMID: 18587387
14. Holt N, Wang J, Kim K, Friedman G, Wang X, Taupin V, et al. (2010) Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 28: 839-847. doi: 10.1038/nbt.1663 PMID: 20601939
15. Sung YH, Baek IJ, Kim DH, Jeon J, Lee J, Lee K, et al. (2013) Knockout mice created by TALEN-mediated gene targeting. Nat Biotechnol 31: 23-24. doi: 10.1038/nbt.2477 PMID: 23302927
16. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339: 819-823. doi: 10.1126/science.1231143 PMID: 23287718
17. Mali P, Esvelt KM, Church GM (2013) Cas9 as a versatile tool for engineering biology. Nat Methods 10: 957-963. doi: 10.1038/nmeth.2649 PMID: 24076990
18. Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, et al. (2013) High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31: 822-826. doi: 10. 1038/nbt.2623 PMID: 23792628
19. Cradick TJ, Fine EJ, Antico CJ, Bao G (2013) CRISPR/Cas9 systems targeting beta-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res 41: 9584-9592. doi: 10.1093/nar/gkt714 PMID: 23939622
20. Mussolino C, Morbitzer R, Lutge F, Dannemann N, Lahaye T, Cathomen T (2011) A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. Nucleic Acids Res 39: 9283-9293. doi: 10.1093/nar/gkr597 PMID: 21813459
21. Sakuma T, Ochiai H, Kaneko T, Mashimo T, Tokumasu D, Sakane Y, et al. (2013) Repeating pattern of non-RVD variations in DNA-binding modules enhances TALEN activity. Sci Rep 3: 3379. doi: 10.1038/srep03379 PMID: 24287550
22. Craigie R, Bushman FD (2012) HIV DNA Integration. Cold Spring Harb Perspect Med 2: a006890. doi: 10.1101/cshperspect.a006890 PMID: 22762018
23. Siliciano RF, GreeneWC (2011) HIV latency. Cold Spring Harb Perspect Med 1: a007096. doi: 10. 1101/cshperspect.a007096 PMID: 22229121
24. Eisele E, Siliciano RF (2012) Redefining the viral reservoirs that prevent HIV-1 eradication. Immunity 37: 377-388. doi: 10.1016/j.immuni.2012.08.010 PMID: 22999944
25. Qu X, Wang P, Ding D, Li L, Wang H, Ma L, et al. (2013) Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells. Nucleic Acids Res 41: 7771-7782. doi: 10.1093/nar/gkt571 PMID: 23804764
26. Ebina H, Misawa N, Kanemura Y, Koyanagi Y (2013) Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci Rep 3: 2510. doi: 10.1038/srep02510 PMID: 23974631
27. Kawano Y, Yoshida T, Hieda K, Aoki J, Miyoshi H, Koyanagi Y (2004) A lentiviral cDNA library employing lambda recombination used to clone an inhibitor of human immunodeficiency virus type 1-induced cell death. J Virol 78: 11352-11359. PMID: 15452256
28. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM (1998) Development of a self-inactivating lentivirus vector. J Virol 72: 8150-8157. PMID: 9733856
29. Miyoshi I, Taguchi H, Kubinishi I, Yoshimoto S, Ohtsuki Y, Shiraishi Y, et al. (1982) Type C virus-producing cell lines derived from adult T-cell leukemia. In: Hanaoka M, Takatsuki K, Shimoyama M, editors. Gann monographs on cancer research. Tokyo: Japan Scientific Societies Press. pp. 219-237.
30. Clouse KA, Powell D, Washington I, Poli G, Strebel K, Farrar W, et al. (1989) Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J Immunol 142: 431-438. PMID: 2463307
31. Kawano Y, Tanaka Y, Misawa N, Tanaka R, Kira JI, Kimura T, et al. (1997) Mutational analysis of human immunodeficiency virus type 1 (HIV-1) accessory genes: requirement of a site in the nef gene for HIV-1 replication in activated CD4+ T cells in vitro and in vivo. J Virol 71: 8456-8466. PMID: 9343202
32. Ebina H, Kanemura Y, Suzuki Y, Urata K, Misawa N, Koyanagi Y (2012) Integrase-independent HIV-1 infection is augmented under conditions of DNA damage and produces a viral reservoir. Virology 427: 44-50. doi: 10.1016/j.virol.2012.02.004 PMID: 22374236
33. Yamamoto SP, Okawa K, Nakano T, Sano K, Ogawa K, Masuda T, et al. (2011) Huwe1, a novel cellular interactor of Gag-Pol through integrase binding, negatively influences HIV-1 infectivity. Microbes Infect 13: 339-349. doi: 10.1016/j.micinf.2010.12.002 PMID: 21167302
34. Shinoda Y, Hieda K, Koyanagi Y, Suzuki Y (2009) Efficient transduction of cytotoxic and anti-HIV-1 genes by a gene-regulatable lentiviral vector. Virus Genes 39: 165-175. doi: 10.1007/s11262-009-0382-x PMID: 19554442
35. Godbey WT, Zhang X, Chang F (2008) The importance of and a method for including transfection efficiency into real-time PCR data analyses. Biotechnol Bioeng 100: 765-772. doi: 10.1002/bit.21811 PMID: 18306419
36. Suzuki Y, Misawa N, Sato C, Ebina H, Masuda T, Yamamoto N, et al. (2003) Quantitative analysis of human immunodeficiency virus type 1 DNA dynamics by real-time PCR: integration efficiency in stimulated and unstimulated peripheral blood mononuclear cells. Virus Genes 27: 177-188. PMID: 14501196
37. Doyle EL, Booher NJ, Standage DS, Voytas DF, Brendel VP, Vandyk JK, et al. (2012) TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction. Nucleic Acids Res 40: W117-122. doi: 10.1093/nar/gks608 PMID: 22693217
38. Osborn MJ, Starker CG, McElroy AN, Webber BR, Riddle MJ, Xia L, et al. (2013) TALEN-based gene correction for epidermolysis bullosa. Mol Ther 21: 1151-1159. doi: 10.1038/mt.2013.56 PMID: 23546300
39. Lee K, Ambrose Z, Martin TD, Oztop I, Mulky A, Julias JG, et al. (2010) Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe 7: 221-233. doi: 10.1016/j.chom.2010.02.007 PMID: 20227665
40. Duda K, Lonowski LA, Kofoed-Nielsen M, Ibarra A, Delay CM, Kang Q, et al. (2014) High-efficiency genome editing via 2A-coupled co-expression of fluorescent proteins and zinc finger nucleases or CRISPR/Cas9 nickase pairs. Nucleic Acids Res.
41. Pelascini LP, Maggio I, Liu J, Holkers M, Cathomen T, Goncalves MA (2013) Histone deacetylase inhibition rescues gene knockout levels achieved with integrase-defective lentiviral vectors encoding zincfinger nucleases. Hum Gene Ther Methods 24: 399-411. doi: 10.1089/hgtb.2013.107 PMID: 24059449
42. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110: 521-529. PMID: 12202041
43. Mitchell R, Chiang CY, Berry C, Bushman F (2003) Global analysis of cellular transcription following infection with an HIV-based vector. Mol Ther 8: 674-687. PMID: 14529841
44. Lewinski MK, Bisgrove D, Shinn P, Chen H, Hoffmann C, Hannenhalli S, et al. (2005) Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J Virol 79: 6610-6619. PMID: 15890899
45. Tebas P, Stein D, Tang WW, Frank I, Wang SQ, Lee G, et al. (2014) Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med 370: 901-910. doi: 10.1056/ NEJMoa1300662 PMID: 24597865
46. Mandal PK, Ferreira LM, Collins R, Meissner TB, Boutwell CL, Friesen M, et al. (2014) Efficient Ablation of Genes in Human Hematopoietic Stem and Effector Cells using CRISPR/Cas9. Cell Stem Cell 15: 643-652. doi: 10.1016/j.stem.2014.10.004 PMID: 25517468